Facilitation of Insulin Effects by Ranolazine in Astrocytes in Primary Culture

Ranolazine (Rn) is a drug used to treat persistent chronic coronary ischemia. It has also been shown to have therapeutic benefits on the central nervous system and an anti-diabetic effect by lowering blood glucose levels; however, no effects of Rn on cellular sensitivity to insulin (Ins) have been d...

Descripción completa

Detalles Bibliográficos
Autores principales: Jordá, Adrián, Aldasoro, Martin, Campo-Palacio, Ignacio, Vila, Jose M., Aldasoro, Constanza, Campos-Campos, Juan, Colmena, Carlos, Singh, Sandeep Kumar, Obrador, Elena, Valles, Soraya L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569909/
https://www.ncbi.nlm.nih.gov/pubmed/36233271
http://dx.doi.org/10.3390/ijms231911969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569909/
https://www.ncbi.nlm.nih.gov/pubmed/36233271
http://dx.doi.org/10.3390/ijms231911969

Ejemplares similares